Top

Journal of Assisted Reproduction and Genetics

Published in:

01-11-2019 | Infertility | Assisted Reproduction Technologies

The impact of peak estradiol during controlled ovarian stimulation on the cumulative live birth rate of IVF/ICSI in non-PCOS patients

Authors: Wanlin Zhang, Ying Tian, Duo Xie, Ye Miao, Jin Liu, Xiaohong Wang

Published in: Journal of Assisted Reproduction and Genetics | Issue 11/2019

Abstract

Objective

The study aimed to investigate the impact of the peak E2 level during controlled ovarian hyperstimulation (COS) on the cumulative live birth rate (cLBR) in non-PCOS women with normal ovarian reserve.

Materials and methods

Women between 20 and 39 years were included. Donor cycles and patients who never experienced embryo transfer were excluded. Multivariable regression and smooth curve fitting were applied for statistical analysis.

Results

A total of 1141 patients were included. The mean age, basal AFC, peak E2 level, and number of retrieved oocyte were 30.0 ± 3.7 years old, 16.8 ± 6.7, 3911.0 ± 1302.9 pg/ml, and 13.6 ± 5.5, respectively. In the overall population of the cohort, cLBR, miscarriage rate, and preterm birth rate were 66.9%, 7.4%, and 13.7%, respectively. The results of multivariable regression analysis failed to show the impact of peak E2 on the cLBR [OR (95%CI) 0.995 (0.982, 1.009), P = 0.486]. However, the result of smooth curve fitting indicated that when the peak E2 was lower than 2185 pg/ml, the cLBR increased about 12% with 100 pg/ml increasing of the peak E2. When the peak E2 was higher than 6136 pg/ml, the cLBR decreased about 10% with 100 pg/ml increasing of the peak E2.

Conclusion

We concluded that the peak E2 level on hCG trigger day is associated with the cLBR in a segmental pattern. There should be an appropriate range of the peak E2 level during COS to achieve a relative best cLBR in non-PCOS patients using stimulating protocol mainly based on GnRH agonist; however, the cutoff value must vary in different centers.

Available only for authorised users

Crawford GE, Ledger WL. In vitro fertilisation/intracytoplasmic sperm injection beyond 2020. BJOG. 2019;126(2):237–43. https://doi.org/10.1111/1471-0528.15526.CrossRefPubMed

De Neubourg D, Bogaerts K, Blockeel C, Coetsier T, Delvigne A, Devreker F, et al. How do cumulative live birth rates and cumulative multiple live birth rates over complete courses of assisted reproductive technology treatment per woman compare among registries? Hum Reprod (Oxford, England). 2016;31(1):93–9. https://doi.org/10.1093/humrep/dev270.CrossRef

Imudia AN, Goldman RH, Awonuga AO, Wright DL, Styer AK, Toth TL. The impact of supraphysiologic serum estradiol levels on peri-implantation embryo development and early pregnancy outcome following in vitro fertilization cycles. J Assist Reprod Genet. 2014;31(1):65–71. https://doi.org/10.1007/s10815-013-0117-8.CrossRefPubMed

Kara M, Kutlu T, Sofuoglu K, Devranoglu B, Cetinkaya T. Association between serum estradiol level on the hCG administration day and IVF-ICSI outcome. Iran J Reprod Med. 2012;10(1):53–8.PubMedPubMedCentral

Rehman R, Jawaid S, Gul H, Khan R. Impact of peak estradiol levels on reproductive outcome of intracytoplasmic sperm injection. Pak J Med Sci. 2014;30(5):986–91. https://doi.org/10.12669/pjms.305.5175.CrossRefPubMedPubMedCentral

Wei M, Zhang XM, Gu FL, Lv F, Ji YR, Liu KF, et al. The impact of LH, E2, and P level of HCG administration day on outcomes of in vitro fertilization in controlled ovarian hyperstimulation. Clin Exp Obstet Gynecol. 2015;42(3):361–6.PubMed

Siddhartha N, Reddy NS, Pandurangi M, Tamizharasi M, Radha V, Kanimozhi K. Correlation of serum estradiol level on the day of ovulation trigger with the reproductive outcome of intracytoplasmic sperm injection. J Hum Reprod Sci. 2016;9(1):23–7. https://doi.org/10.4103/0974-1208.178631.CrossRefPubMedPubMedCentral

Bu Z, Wang K, Guo Y, Su Y, Zhai J, Sun Y. Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer. Int J Clin Exp Med. 2015;8(7):11327–31.PubMedPubMedCentral

Committee Opinion No. 690: Carrier Screening in the Age of Genomic Medicine. Obstet Gynecol. 2017;129(3):e35–40. https://doi.org/10.1097/aog.0000000000001951.

10.

Christianson MS, Shoham G, Tobler KJ, Zhao Y, Cordeiro CN, Leong M, et al. Measurement of antral follicle count in patients undergoing in vitro fertilization treatment: results of a worldwide web-based survey. J Assist Reprod Genet. 2015;32(10):1435–40. https://doi.org/10.1007/s10815-015-0555-6.CrossRefPubMedPubMedCentral

11.

Group EASPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod. 2004;81(1):19–25.

12.

Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Reprod Biomed Online. 2011;22(6):632–46. https://doi.org/10.1016/j.rbmo.2011.02.001.CrossRef

13.

Vrtacnik P, Ostanek B, Mencej-Bedrac S, Marc J. The many faces of estrogen signaling. Biochem Med (Zagreb). 2014;24(3):329–42. https://doi.org/10.11613/bm.2014.035.CrossRef

14.

Foroozanfard F, Moraveji SA, Taghavi SA, Karimi F. Association between serum estradiol level on the day of hCG administration and IVF-ICSI outcome. J Obstet Gynaecol India. 2016;66(3):170–3. https://doi.org/10.1007/s13224-015-0687-8.CrossRefPubMed

15.

Joo BS, Park SH, An BM, Kim KS, Moon SE, Moon HS. Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner. Fertil Steril. 2010;93(2):442–6. https://doi.org/10.1016/j.fertnstert.2009.02.066.CrossRefPubMed

16.

Pereira N, Reichman DE, Goldschlag DE, Lekovich JP, Rosenwaks Z. Impact of elevated peak serum estradiol levels during controlled ovarian hyperstimulation on the birth weight of term singletons from fresh IVF-ET cycles. J Assist Reprod Genet. 2015;32(4):527–32. https://doi.org/10.1007/s10815-015-0434-1.CrossRefPubMedPubMedCentral

17.

Pereira N, Elias RT, Christos PJ, Petrini AC, Hancock K, Lekovich JP, et al. Supraphysiologic estradiol is an independent predictor of low birth weight in full-term singletons born after fresh embryo transfer. Hum Reprod. 2017;32(7):1410–7. https://doi.org/10.1093/humrep/dex095.CrossRefPubMedPubMedCentral

18.

Imudia AN, Awonuga AO, Doyle JO, Kaimal AJ, Wright DL, Toth TL, et al. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization. Fertil Steril. 2012;97(6):1374–9. https://doi.org/10.1016/j.fertnstert.2012.03.028.CrossRefPubMed

19.

Chen ZJ, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, et al. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N Engl J Med. 2016;375(6):523–33. https://doi.org/10.1056/NEJMoa1513873.CrossRefPubMed

20.

Shi Y, Sun Y, Hao C, Zhang H, Wei D, Zhang Y, et al. Transfer of fresh versus frozen embryos in ovulatory women. N Engl J Med. 2018;378(2):126–36. https://doi.org/10.1056/NEJMoa1705334.CrossRefPubMed

21.

Vuong LN, Dang VQ, Ho TM, Huynh BG, Ha DT, Pham TD, et al. IVF transfer of fresh or frozen embryos in women without polycystic ovaries. N Engl J Med. 2018;378(2):137–47. https://doi.org/10.1056/NEJMoa1703768.CrossRefPubMed

22.

Wei D, Liu JY, Sun Y, Shi Y, Zhang B, Liu JQ, et al. Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial. Lancet (London, England). 2019;393(10178):1310–8. https://doi.org/10.1016/s0140-6736(18)32843-5.CrossRef

23.

Ng EH, Chan CC, Tang OS, Yeung WS, Ho PC. Comparison of endometrial and subendometrial blood flow measured by three-dimensional power Doppler ultrasound between stimulated and natural cycles in the same patients. Hum Reprod (Oxford, England). 2004;19(10):2385–90. https://doi.org/10.1093/humrep/deh384.CrossRef

24.

Ng EH, Chan CC, Tang OS, Yeung WS, Ho PC. Factors affecting endometrial and subendometrial blood flow measured by three-dimensional power Doppler ultrasound during IVF treatment. Hum Reprod (Oxford, England). 2006;21(4):1062–9. https://doi.org/10.1093/humrep/dei442.CrossRef

25.

Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A, et al. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril. 2002;78(5):1025–9.CrossRefPubMed

26.

Lee YL, Liu Y, Ng PY, Lee KF, Au CL, Ng EH, et al. Aberrant expression of angiopoietins-1 and -2 and vascular endothelial growth factor-a in peri-implantation endometrium after gonadotrophin stimulation. Hum Reprod (Oxford, England). 2008;23(4):894–903. https://doi.org/10.1093/humrep/den004.CrossRef

27.

Zapantis G, Szmyga MJ, Rybak EA, Meier UT. Premature formation of nucleolar channel systems indicates advanced endometrial maturation following controlled ovarian hyperstimulation. Hum Reprod (Oxford, England). 2013;28(12):3292–300. https://doi.org/10.1093/humrep/det358.CrossRefPubMedCentral

28.

Li MQ, Jin LP. Ovarian stimulation for in vitro fertilization alters the protein profile expression in endometrial secretion. Int J Clin Exp Pathol. 2013;6(10):1964–71.PubMedPubMedCentral

29.

Ullah K, Rahman TU, Pan HT, Guo MX, Dong XY, Liu J, et al. Serum estradiol levels in controlled ovarian stimulation directly affect the endometrium. J Mol Endocrinol. 2017;59(2):105–19. https://doi.org/10.1530/jme-17-0036.CrossRefPubMedPubMedCentral

30.

Namavar Jahromi BMD, Parsanezhad MEMD, Shomali ZMD, Bakhshai PMD, Alborzi MMD, Moin Vaziri NMDP, et al. Ovarian Hyperstimulation syndrome: a narrative review of its pathophysiology, risk factors, prevention, classification, and management. Iranian J Med Sci. 2018;43(3):248–60.

31.

Zhang W, Ma Y, Xiong Y, Xiao X, Chen S, Wang X. Supraphysiological serum oestradiol negatively affects birthweight in cryopreserved embryo transfers: a retrospective cohort study. Reprod BioMed Online. 2019. https://doi.org/10.1016/j.rbmo.2019.04.015.CrossRefPubMed

32.

Tarumi W, Itoh MT, Suzuki N. Effects of 5α-dihydrotestosterone and 17β-estradiol on the mouse ovarian follicle development and oocyte maturation. PLoS One. 2014;9(6):e99423-e. https://doi.org/10.1371/journal.pone.0099423.CrossRef

33.

Gelbaya TA, Potdar N, Jeve YB, Nardo LG. Definition and epidemiology of unexplained infertility. Obstet Gynecol Surv. 2014;69(2):109–15. https://doi.org/10.1097/ogx.0000000000000043.CrossRefPubMed

34.

Somigliana E, Paffoni A, Busnelli A, Filippi F, Pagliardini L, Vigano P, et al. Age-related infertility and unexplained infertility: an intricate clinical dilemma. Hum Reprod (Oxford, England). 2016;31(7):1390–6. https://doi.org/10.1093/humrep/dew066.CrossRef

35.

Ge ZJ, Schatten H, Zhang CL, Sun QY. Oocyte ageing and epigenetics. Reproduction (Cambridge, England). 2015;149(3):R103–14. https://doi.org/10.1530/rep-14-0242.CrossRef

36.

Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res. 2002;57:257–75.CrossRefPubMed

37.

Luke B. Pregnancy and birth outcomes in couples with infertility with and without assisted reproductive technology: with an emphasis on US population-based studies. Am J Obstet Gynecol. 2017;217(3):270–81. https://doi.org/10.1016/j.ajog.2017.03.012.CrossRefPubMed

38.

Luke B, Gopal D, Cabral H, Stern JE, Diop H. Adverse pregnancy, birth, and infant outcomes in twins: effects of maternal fertility status and infant gender combinations; the Massachusetts outcomes study of assisted reproductive technology. Am J Obstet Gynecol. 2017;217(3):330.e1–e15. https://doi.org/10.1016/j.ajog.2017.04.025.CrossRef

Title: The impact of peak estradiol during controlled ovarian stimulation on the cumulative live birth rate of IVF/ICSI in non-PCOS patients
Authors: Wanlin Zhang
Ying Tian
Duo Xie
Ye Miao
Jin Liu
Xiaohong Wang
Publication date: 01-11-2019
Publisher: Springer US
Keywords: Infertility
ICSI
Infertility
Miscarriage
Estradiol
GnRH Agonists
Published in: Journal of Assisted Reproduction and Genetics / Issue 11/2019
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-019-01568-w

At a glance: The STEP trials

Springer Medicine

The impact of peak estradiol during controlled ovarian stimulation on the cumulative live birth rate of IVF/ICSI in non-PCOS patients

Abstract

Objective

Materials and methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Objective

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2019

Defining the role of FMR1 gene in unexplained recurrent spontaneous abortion

Revisiting debates of premature luteinization and its effect on assisted reproductive technology outcome

Embryo transfer strategy and therapeutic options in infertile patients with thin endometrium: a systematic review

Performance of Day 5 KIDScore™ morphokinetic prediction models of implantation and live birth after single blastocyst transfer

Impact of hypogonadotropic hypogonadism on ovarian reserve and response

Correction to: Contribution of cryopreservation to the cumulative live birth rate: a large multicentric cycle-based data analysis from the Italian National Registry